Anti-tumor necrosis factor biosimilars and intended copies in rheumatology: Perspective from the Asia Pacific region. [electronic resource]
Producer: 20190529Description: 9-24 p. digitalISSN:- 1756-185X
- Antirheumatic Agents -- adverse effects
- Asia
- Australia
- Biological Products -- adverse effects
- Biosimilar Pharmaceuticals -- adverse effects
- Drug Approval
- Drug Development -- legislation & jurisprudence
- Government Regulation
- Humans
- Patient Safety
- Policy Making
- Practice Guidelines as Topic
- Rheumatic Diseases -- diagnosis
- Rheumatology -- legislation & jurisprudence
- Risk Assessment
- Terminology as Topic
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.